Fox, Elizabeth <br/><br/>
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.  [electronic resource] 

 -  Blood  Jan 2008 
 - 566-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-08-107839  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abdominal Pain--chemically induced<br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--adverse effects<br/>Arsenic Trioxide<br/>Arsenicals--adverse effects<br/>Child<br/>Child, Preschool<br/>Constipation--chemically induced<br/>Dermatitis--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Headache--chemically induced<br/>Humans<br/>Hyperglycemia--chemically induced<br/>Infusions, Intravenous<br/>Leukemia, Promyelocytic, Acute--complications<br/>Lymphoma--complications<br/>Male<br/>Nausea--chemically induced<br/>Oxides--adverse effects<br/>Pancreatitis--chemically induced<br/>Pneumonia--chemically induced<br/>Recurrence<br/>Time Factors<br/>Vomiting--chemically induced<br/>Water-Electrolyte Balance--drug effects